Showing 1821-1830 of 23125 results for "".
Improving CRC Screening Uptake: An Integrated Approach
https://reachmd.com/programs/clinicians-roundtable/increase-crc-screening-uptake-integrated/56445/A recent retrospective study evaluated how combining shared decision making and EHR-enabled workflow optimization impacted colorectal cancer (CRC) screening adherence among patients aged 45 and older. Learn more as Dr. Mallik Greene dives into the details and explains how this approach could imprThe Future of MS Management: Novel Agents and Clinical Approaches
https://reachmd.com/programs/neurofrontiers/program-name/36360/The multiple sclerosis (MS) treatment landscape is rapidly evolving, with novel approaches on the horizon that may transform care for progressive patients. Explore the latest phase 3 data on BTK inhibitors like tolebrutinib and gain insights into ongoing CAR T-cell and remyelination research, includAdvances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
https://reachmd.com/programs/neurofrontiers/advances-in-dmd-care-evaluating-a-gene-therapys-efficacy-and-safety/26327/Explore the efficacy and safety data that led to the expanded approval of a gene therapy for patients with Duchenne muscular dystrophy.Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
https://reachmd.com/programs/neurofrontiers/negative-symptoms-in-schizophrenia/39940/Negative symptoms of schizophrenia—such as emotional flatness, social withdrawal, and lack of motivation—are often subtle, persistent, and underrecognized, yet they significantly impact patient functioning and quality of life. To learn more about this hidden burden, Dr. Alexandria May speaks with DrAnti-OX40 Ligand Antibody Trials
https://reachmd.com/series/updates-atopic-dermatitis/anti-ox40-ligand-antibody-trials/29531/Lead study author Stephan Weidinger, MD, PhD, Director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein, discusses the phase 2b STREAM-AD trial, evaluating amlitelimab in adult patients with moderate-to-severe atopic dermatitis.ADHD and the Presence of High IQ
https://reachmd.com/programs/clinicians-roundtable/adhd-and-the-presence-of-high-iq/2397/Traditional wisdom says that people with ADHD have lower IQs. Is it possible to have ADHD and a high IQ? Syracuse University psychologist Dr. Kevin Antshel joins host Dr. Leslie Lundt to discuss twice exceptional children.Understanding the Role of the Alternate Complement Pathway in PNH
https://reachmd.com/programs/project-oncology/understanding-the-role-of-the-alternate-complement-pathway-in-pnh/48875/How does the alternate complement pathway apply in the PNH treatment landscape? Tune in to learn more about its role.Exploring Patient Perspectives on Genetic Testing for ATTR-CM
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/exploring-patient-perspectives-on-genetic-testing-for-attr-cm/39317/Genetic testing is a very valuable tool in managing transthyretin amyloid cardiomyopathy (ATTR-CM), but many patients face emotional, educational, and systemic barriers throughout. To learn more about the patient perspective of this process, researchers conducted interviews with ATTR-CM patients andPredicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
https://reachmd.com/programs/project-oncology/predicting-hydroxyurea-resistance-in-polycythemia-vera-with-machine-learning/37210/Early resistance to hydroxyurea in patients with polycythemia vera (PV) is associated with higher risks of thromboembolic complications, disease progression, and mortality. The PV-AIM study applied machine learning to real-world data and identified simple lab-based predictors that stratify patientsUnmasking IgG4-Related Disease: Best Practices for Accurate Diagnosis and Optimal Care
https://reachmd.com/programs/living-rheum/unmasking-igg4-related-disease-best-practices-for-accurate-diagnosis-and-optimal-care/32788/IgG4-related disease presents significant diagnostic challenges with diverse symptoms across organ systems. Dr. Matthew Baker, Associate Division Chief in the Division of Immunology and Rheumatology at Stanford University and the Co-Founder and Co-Director of the Stanford Multidisciplinary Sarcoidos